More about

Car T-Cell Therapy

News
December 18, 2024
2 min watch
Save

VIDEO: Treatment regimen appears safe, effective in aggressive non-Hodgkin lymphoma

VIDEO: Treatment regimen appears safe, effective in aggressive non-Hodgkin lymphoma

SAN DIEGO — A treatment regimen of loncastuximab tesirine combined with venetoclax may be safe and effective in a subset of patients with non-Hodgkin lymphoma, according to early research presented at ASH Annual Meeting and Exposition.

News
December 17, 2024
2 min read
Save

CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis

CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis

WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over a period of up to 15 months in 35 patients with lupus, myositis and systemic sclerosis, according to data.

News
December 10, 2024
3 min read
Save

Axi-cel exhibits durable benefit in advanced indolent non-Hodgkin lymphoma

Axi-cel exhibits durable benefit in advanced indolent non-Hodgkin lymphoma

SAN DIEGO — Treatment with axicabtagene ciloleucel conferred durable benefit to patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, according to study results presented at ASH Annual Meeting and Exposition.

News
December 09, 2024
3 min read
Save

Tandem non-cryopreserved CAR-T exhibits ‘favorable’ activity in advanced DLBCL

Tandem non-cryopreserved CAR-T exhibits ‘favorable’ activity in advanced DLBCL

SAN DIEGO — A rapidly delivered tandem chimeric antigen receptor T-cell therapy produced favorable outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma, according to interim results of a phase 2 trial.

News
November 27, 2024
2 min read
Save

BLOG: Course offers ‘exceptional’ opportunity to engage in scientific, career discussions

BLOG: Course offers ‘exceptional’ opportunity to engage in scientific, career discussions

I was truly honored to be selected as a scholar for the inaugural ASTCT Laboratory Science Training Course in July.

News
November 13, 2024
4 min read
Save

CAR T-cell therapy produces ‘jaw dropping’ results for deadly pediatric brain tumors

CAR T-cell therapy produces ‘jaw dropping’ results for deadly pediatric brain tumors

Chimeric antigen receptor T-cell therapy can reduce tumor burden and improve neurologic function for patients with certain brain and spinal cord cancers, a first-in-human clinical trial showed.

News
October 23, 2024
8 min read
Save

Novel techniques may provide ‘incredible’ benefits to enhance CAR T-cell therapy

Novel techniques may provide ‘incredible’ benefits to enhance CAR T-cell therapy

Multiple studies published since this summer suggest chimeric antigen receptor T-cell therapies are comparably effective in real-world settings as they have been in pivotal clinical trials.

News
October 08, 2024
2 min watch
Save

VIDEO: Patient treatment planning in myeloma begins with transplant eligibility decision

VIDEO: Patient treatment planning in myeloma begins with transplant eligibility decision

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses how she approaches putting together a treatment plan for a patient with multiple myeloma.

News
October 08, 2024
2 min watch
Save

VIDEO: Targeted therapies, CELMoDs in development for multiple myeloma

VIDEO: Targeted therapies, CELMoDs in development for multiple myeloma

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses some of the new treatments in the pipeline for multiple myeloma.

View more